Search Results 1-10 of 16 for albumin

1. Effectiveness of Departmental Education on Reducing 5% Albumin Administration - Mayo Clinic

   With the knowledge obtained, department wide education will be developed and offered to all anesthesia providers imparting appropriate uses of albumin, based on the current research.

2. A Study Using Lactated Ringer's Solution versus 5%Human Albumin in Cardiac Surgery Patients - Mayo Clinic

   Our hypothesis is that the individual total fluid volume will be less with 5% human albumin compared to Lactated Ringer's in the perioperative cardiac surgical patient.

3. Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   Drugs used in chemotherapy, such as paclitaxel albumin-stabilized nanoparticle formulation, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them f...

4. Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations - Mayo Clinic

   Patients then receive nanoparticle albumin-bound rapamycin, which may stop the growth of cancer cells by blocking the mTOR enzyme, which is needed for cell growth and multiplication.

5. A Study of Short-term Survival in Subjects With Acute-on-chronic Liver Failure After Plasma Exchange With Human Serum Albumin 5% - Mayo Clinic

   Study IDs Site IRB Rochester, Minnesota: 18-005196 NCT ID: NCT03702920 Sponsor Protocol Number: IG1407 About this study The purpose of this study is to evaluate the effects of plasma exchange using human serum albumin 5% (PE-A 5%) in...

6. Effects of Long-Term Administration of Human Albumin in Subjects With Decompensated Cirrhosis and Ascites - Mayo Clinic

   Overview Tab Title Description Study type Interventional Study phase 3 Study IDs Study type Interventional Describes the nature of a clinical study. Types include: Observational study - observes people and measures outcomes without affecting results....

7. Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients with Stage IV Melanoma and Gynecologic Cancers That Cannot Be Removed by Surgery - Mayo Clinic

   Giving paclitaxel albumin-stabilized nanoparticle formulation and bevacizumab may kill more tumor cells.

8. Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab or Ipilimumab as First-Line Therapy in Treating Patients with Stage IV Melanoma that Cannot be Removed by Surgery - Mayo Clinic

   It is not yet known whether paclitaxel albumin-stabilized nanoparticle formulation and bevacizumab is more effective than ipilimumab in treating melanoma.

9. A Study of Markers in the Blood and/or Stored Kidney Biopsy Tissue in Patients with a History of Childhood Onset of Membranous Nephropathy - Mayo Clinic

   Overview Tab Title Description Study type Observational Study IDs Study type Observational Describes the nature of a clinical study. Types include: Observational study - observes people and measures outcomes without affecting results. Interventional ...

10. LS1681: A Study of AR160 in Treating Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma - Mayo Clinic

    AR160 is a combination of paclitaxel albumin-stabilized nanoparticle formulation and rituximab.